Skip to content

Taxes Paid at other companies

Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$627K+56.8%
Arrowhead Research logo
Arrowhead ResearchARWR
$11.66M+16,554%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$300K-50.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$8K+98.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.63B-2.6%
Tenet Healthcare logo
Tenet HealthcareTHC
$8M+14.3%

Other financials

Income statement

See full
Revenue$204.9M+69.6%
Gross profit$171.4M+62.8%
Operating income$34.8M+304%
Net income$19.8M+291%
EPS (diluted)$0.12+300%

Balance sheet

See full
Cash & equivalents$442.2M+235%
Total debt$753.6M+197%
Total equity$583.1M+146%
Total assets$1.5B+133%

Cash flow

See full
Operating cash flow-$17.9M+37.7%
CapEx$51.0K+104%
Free cash flow-$17.9M+37.6%

Valuation

See full
Market cap$8.15B-14.3%
Enterprise value$8.46B-11.1%
P/E17.6×-225×
P/S11.6×-13.0×

Profitability

See full
Gross margin83.1%-4.4pp
Operating margin21.3%+5.9pp
Net margin66%+55.8pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity112.6%+92.9pp
Debt / equity1.3×+0.2×
Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TG Therapeutics's taxes paid?
TG Therapeutics (TGTX) reported taxes paid of $3.44M in Q1 2026.
What does taxes paid mean?
The actual cash amount paid to government authorities for income taxes.
How do you interpret taxes paid?
Significant deviations between tax expense and taxes paid can signal changes in deferred tax assets or liabilities and future cash flow implications.
How does taxes paid compare across companies?
Highly dependent on regional tax jurisdictions and the company's profitability profile.